Amneal Pharmaceuticals In...

NASDAQ: AMRX · Real-Time Price · USD
9.36
-0.03 (-0.32%)
At close: Aug 15, 2025, 2:17 PM

Amneal Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
35.61M 24.62M -20.74M 11.76M 16.79M -81.68M -93.34M 25.03M 29.68M -10.09M -5.86M -2.39M -240.08M -6.46M -20.46M -6.09M 32.18M 14.54M
Depreciation & Amortization
60.11M 60.16M 66.13M 58.96M 55.57M 55.53M 56.93M 57.21M 57.11M 58.15M 61.06M 61.61M 59.7M 57.81M 61.18M 60.19M 56.49M 55.55M
Stock-Based Compensation
8.27M 7.26M 7.21M 7.11M 6.72M 6.72M 5.97M 6.69M 6.56M 7.6M 7.83M 7.69M 8.26M 8.06M 7.74M 7.71M 7.63M 5.33M
Other Working Capital
-3.08M -1.64M 35.23M 17.06M 7.35M -6.21M 19.32M -7.33M 3.86M -22.98M 45.02M 79.98M n/a 713K 7.25M -3.76M -24.68M 4.16M
Other Non-Cash Items
14.93M 21.75M 43.63M 21.18M 17.29M 26.99M 102.68M 27.2M 15.75M 29.78M 48.89M 20.99M 3.22M 10.27M -6.25M 18.96M 3.62M 3.61M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a 9.88M -2.08M n/a n/a n/a n/a n/a n/a 42.8M 4.05M 12.59M 14.05M
Change in Working Capital
-35.11M -106.38M 21.86M 42.77M -56.72M -11.97M 53.7M -34.74M -120.43M 54.28M -135.21M 5.67M 18.94M 50.66M -21.75M -2.45M -164.44M 55.04M
Operating Cash Flow
83.82M 7.41M 118.08M 141.77M 39.66M -4.41M 135.82M 81.39M -11.35M 139.71M -23.29M 93.57M -125.52M 120.34M 63.26M 82.36M -51.93M 148.13M
Capital Expenditures
-26.5M -18.32M -23.06M -20.71M -11.45M -19.76M -11.79M -13.48M -12.28M -11.74M -11.47M -49.33M -17.12M -12.68M -19.25M -11.63M -9.06M -12.69M
Cash Acquisitions
855K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -84.71M -72.72M n/a -73.83M n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a -4.64M 6.41M -3.6M 4.24M -9.7M -19.9M -1M -1.15M -338K -44.19M -31.8M -9M -84.71M 5M n/a -74.33M -917K
Investing Cash Flow
-26.55M -17.8M -16.06M -20.71M -6.46M -19.76M -31.69M -13.48M -12.28M -11.74M -11.47M -49.33M -16.12M -97.39M -86.97M -11.63M -82.89M -12.69M
Debt Repayment
-17.29M -17.53M -55.53M -87.21M -27M -15.38M -262.57M -63.94M -14.91M -72.66M -17.65M -42.61M 31.79M -9.8M -9.85M -34.36M -10.25M -23.72M
Common Stock Repurchased
n/a -21.64M -387K -194K -159K -7.21M 2.03M -189K -11K -2.02M -88K -192K -290K -3M -69K -217K -276K -2.1M
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-25.08M -21.71M -6.02M -4.94M -8.09M -7.78M 161.74M -22.45M 2.66M 61.78M -4.51M -3.33M -8.54M -51.77M -20.5M -8.97M -27.82M -2.43M
Financial Cash Flow
-41.69M -39.17M -61.2M -92.35M -35.09M -23.16M -100.83M -86.58M -12.26M -12.9M -22.17M -46.13M 23.25M -61.57M -30.35M -43.55M -38.07M -26.15M
Net Cash Flow
15.42M -50.03M 40.08M 28.72M -2M -47.49M 3.5M -18.98M -36.49M 115.84M -60.66M -2.29M -118.36M -40.19M -53.88M 27.47M -172.66M 108.69M
Free Cash Flow
57.32M -10.91M 95.01M 121.06M 28.2M -24.17M 104.13M 67.91M -23.63M 127.97M -34.76M 44.24M -142.64M 107.66M 44.01M 70.73M -60.99M 135.44M